Best Glucose Monitors of 2026, Including Over-the-Counter CGMs

Dexcom’s Stelo is the best glucose monitor of 2026. It is an over-the-counter continuous glucose monitor, or CGM, that needs no prescription, lasts up to 15 days per sensor, and since June is cleared for people as young as 2 who do not use insulin. People who take insulin need a prescription device instead, and for them the Dexcom G7 15 Day is our top-ranked option on this page.

How the glucose category was scored

Glucose monitors are medical devices, so this category leaned harder than any other on the published evidence and the exact FDA wording behind each product. The five weighted measures on our published judging criteria still applied, but access had a specific meaning here: whether you can buy the device without a prescription, which phones its app runs on, and whether you can try it without signing up for months. Every claim below comes from the makers’ own documentation, FDA-related announcements and established medical-trade or news outlets. Nothing on this page is medical advice, and no device was worn for this review.

Three kinds of glucose monitor

Before the picks, it helps to know which shelf you are shopping from.

• Over-the-counter CGMs such as Stelo and Lingo stream readings to a phone and are labeled for people who do not use insulin. Abbott states Lingo is not meant to diagnose disease, and Dexcom tells Stelo users not to act on readings alone.
• Prescription CGMs such as Dexcom G7 15 Day, FreeStyle Libre 3 Plus and Eversense 365 are built for diabetes management, include low and high alerts, and connect to insulin pumps or pens.
• Fingerstick meters read a drop of blood on a test strip. They remain the backup that CGM makers tell you to use when a reading and your symptoms disagree.

Winner: Stelo

Stelo was the first glucose biosensor the FDA cleared for over-the-counter sale, in March 2024, and 2026 was the year it widened its reach. Dexcom announced in June that the FDA had expanded its indication from adults 18 and older not using insulin to children 2 and older not using insulin, which coverage at the time described as the first over-the-counter CGM cleared for children. Trade reporting on the clearance noted that children should wear it under a caregiver’s supervision and that wear time can run shorter than the 15-day maximum for younger users.

The second change was software. Dexcom said a fully reimagined Stelo app would launch in July for iPhone and Android users in the US, built to show how food, activity, sleep and stress affect glucose. Stelo’s site describes an AI Coach that offers tips based on your data, with the clear label that those tips are not medical advice, plus morning recaps. Dexcom also offers one-on-one nutrition coaching through Nutrisense, with coverage that varies by insurance plan.

On evidence, Dexcom is unusually open about limits. A footnote on Stelo’s site says 77.9 percent of sensors lasted the full 15 days in a study, so roughly one in five ends early. It also tells users to check with a fingerstick meter when readings do not match how they feel, and not to make medical decisions from Stelo alone.

Access is the strongest point. Stelo is sold as a monthly subscription or as a one-time purchase, it is HSA and FSA eligible, and a compatible phone can pair a new sensor with an Apple Watch.

Who should skip it: anyone who uses insulin, because Stelo is not labeled for them and a prescription system is the right tool.

Finalist: Lingo

Abbott’s over-the-counter CGM is the easiest way for an adult to try continuous glucose data without a commitment. Abbott sells a two-week plan with a single biosensor that it says does not auto-renew, and first-time buyers get a 30-day money-back guarantee. Each sensor streams glucose for up to 14 days, and Abbott promises a free replacement if one stops early.

The app converts readings into a Lingo Count, a measure of glucose impact, and lets you log meals and exercise, review weekly patterns and take on habit challenges. It runs on iOS and Android and shares data with Apple Health or Health Connect.

It finished behind Stelo for one clear reason: Lingo remains labeled for adults 18 and older who are not on insulin, and Abbott states it is not intended to diagnose diseases, including diabetes. Families looking for an over-the-counter option for a teenager will find that only Stelo has that clearance this year.

Finalist: Dexcom G7 15 Day

For adults with diabetes, this is the prescription CGM that moved forward most recently. The FDA cleared it in April 2025 for people over 18 with diabetes, and it became available in the US on December 1, 2025. Dexcom rates wear at 15.5 days, reports an overall mean absolute relative difference, a standard accuracy measure, of 8.0 percent in its own study, and says it works with a range of compatible insulin pumps, pens and health apps.

The fine print is worth reading. Dexcom’s site notes that 73.9 percent of sensors lasted the full 15 days in a study. Children and teens are not covered by this version, and Dexcom says the original G7 remains its pick for ages 2 to 18.

Commended: FreeStyle Libre 3 Plus

Abbott’s prescription sensor lasts up to 15 days, sends a reading every minute and is cleared for ages 2 and up. Abbott says it is the only CGM technology that connects to all leading pump brands in the US, citing its own data on file. Expect a 60-minute warm-up after each new sensor. Its new Libre Assist feature uses generative AI to predict a food’s glucose impact, and Abbott warns that it may not always be accurate and should not drive treatment decisions.

Commended: Eversense 365

Eversense 365 is the only CGM on this list with a sensor that lasts a year. A trained clinician places it under the skin of the upper arm, and a removable smart transmitter sits on top; when the transmitter is off, no data is collected. It is a prescription device for adults 18 and older with diabetes, and the maker lists taking insulin among its candidate criteria. It needs a weekly fingerstick calibration after day 13, and its app runs on iOS, Android and Apple Watch.

Commended: Contour Next One

Every CGM maker tells you to keep a meter handy, and Ascensia’s Contour Next One makes that backup painless. Second-Chance sampling lets you add blood to the same strip instead of starting over, a smartLIGHT turns green, amber or red against your target range, and results sync to the free CONTOUR DIABETES app on compatible Android and iOS phones.

At a glance

Product	Award	Prescription	Labeled for	Sensor life	App platforms
Stelo	Winner	No	Ages 2+, not on insulin	Up to 15 days	iPhone, Android
Lingo	Finalist	No	Adults 18+, not on insulin	Up to 14 days	iOS, Android
Dexcom G7 15 Day	Finalist	Yes	Adults over 18 with diabetes	15.5 days	See Dexcom compatibility list
FreeStyle Libre 3 Plus	Commended	Yes	Ages 2+	Up to 15 days	Compatible phones per Abbott
Eversense 365	Commended	Yes	Adults 18+ with diabetes	One year	iOS, Android, Apple Watch
Contour Next One	Commended	Not stated by maker	Fingerstick meter	Uses test strips	iOS, Android

Matching a monitor to your situation

• Curious about how meals and sleep affect your glucose, not on insulin: start with Stelo, or Lingo if you want a two-week trial with no renewal.
• Parent of a child who does not use insulin: Stelo is the only over-the-counter option cleared below age 18.
• Adult with diabetes on multiple daily injections or a pump: ask about Dexcom G7 15 Day or FreeStyle Libre 3 Plus.
• Tired of replacing a sensor every two weeks: Eversense 365, if your clinician agrees.
• Already on a CGM: keep a Contour Next One for the moments the sensor and your symptoms disagree.

For a closer look at the two over-the-counter rivals, see our guide to Abbott Lingo vs. Dexcom Stelo, and if you are wondering whether a CGM makes sense without diabetes at all, read what CGMs show people without diabetes.

Bottom line for 2026

Over-the-counter CGMs stopped being an adults-only experiment this year, and Stelo is the reason. It pairs the widest clearance in its class with candid published limits and an app that runs on both major phone platforms. On the prescription side, the FDA authorized Abbott’s Libre Duo, a combined glucose and ketone sensor, in August, and Abbott says a US launch is planned for later this year. If you have diabetes, or a reading worries you, talk with your doctor before you change medication, insulin or your treatment plan.

<a href="https://innovationprizes.org/2026/best-glucose-monitors/"><img src="https://innovationprizes.org/badges/2026-best-glucose-monitors-winner.svg" alt="Innovation Prizes 2026 Winner: Glucose Monitors" width="160" height="160"></a>

<a href="https://innovationprizes.org/2026/best-glucose-monitors/"><img src="https://innovationprizes.org/badges/2026-best-glucose-monitors-finalist.svg" alt="Innovation Prizes 2026 Finalist: Glucose Monitors" width="160" height="160"></a>

<a href="https://innovationprizes.org/2026/best-glucose-monitors/"><img src="https://innovationprizes.org/badges/2026-best-glucose-monitors-finalist.svg" alt="Innovation Prizes 2026 Finalist: Glucose Monitors" width="160" height="160"></a>